Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits

Immunological mechanisms have been implicated in the atherogenic process since immunoglobulins are frequently found in the atherosclerotic aorta. We have previously shown that modifications of homologous low density lipoproteins (LDL) make it immunogenic. In particular we have demonstrated that immu...

Full description

Bibliographic Details
Main Authors: O Wiklund, J L Witztum, T E Carew, R C Pittman, R L Elam, D Steinberg
Format: Article
Language:English
Published: Elsevier 1987-09-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520386235
_version_ 1818460019669073920
author O Wiklund
J L Witztum
T E Carew
R C Pittman
R L Elam
D Steinberg
author_facet O Wiklund
J L Witztum
T E Carew
R C Pittman
R L Elam
D Steinberg
author_sort O Wiklund
collection DOAJ
description Immunological mechanisms have been implicated in the atherogenic process since immunoglobulins are frequently found in the atherosclerotic aorta. We have previously shown that modifications of homologous low density lipoproteins (LDL) make it immunogenic. In particular we have demonstrated that immunization with homologous nonenzymatically glucosylated LDL (glcLDL) results in the generation of antibodies specific to the derivatized lysine residue, and that such antibodies do not react with native LDL epitopes. In the present study we immunized rabbits with reductively glucosylated rabbit LDL and then determined the effects of the circulating antibodies on the rates of plasma clearance and on the sites of degradation of LDL in which varying degrees of glucosylation had been achieved. In normal chow-fed animals, the plasma clearance of glcLDL was retarded in proportion to the extent of lysine derivatization. In contrast, in immunized animals the clearance of glcLDL was greatly accelerated. When 10% or more of lysine residues were derivatized, clearance of glcLDL was accelerated 50- to 100-fold. Even when only 5% of lysines were derivatized, plasma clearance was accelerated 2- to 3-fold. Cholesterol feeding inhibited LDL clearance from plasma and decreased LDL uptake of LDL receptor-rich tissues. In a similar manner, glucosylation of LDL inhibited its ability to bind to the LDL receptor and redirected sites of LDL degradation away from LDL receptor-rich tissues. Thus degradation of glcLDL by liver and adrenal was markedly diminished. The presence of antibodies to glcLDL also redirected sites of degradation of the modified LDL, primarily to the reticuloendothelial cells of the liver. There was no evidence for specific targeting of glcLDL-immunoglobulin complexes to the aorta; instead they were targeted to the liver. These data suggest that the presence of humoral antibodies to modified LDL acts to rapidly remove such LDL from plasma and specifically targets such complexes to reticuloendothelial cells, primarily in the liver. In this manner such antibodies may serve a useful purpose.
first_indexed 2024-12-14T23:23:36Z
format Article
id doaj.art-ea8f865b75344e14951cb4a960449b91
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-14T23:23:36Z
publishDate 1987-09-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-ea8f865b75344e14951cb4a960449b912022-12-21T22:43:52ZengElsevierJournal of Lipid Research0022-22751987-09-0128910981109Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbitsO Wiklund0J L Witztum1T E Carew2R C Pittman3R L Elam4D Steinberg5Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Department of Medicine, University of California, San Diego, La Jolla 92093.Immunological mechanisms have been implicated in the atherogenic process since immunoglobulins are frequently found in the atherosclerotic aorta. We have previously shown that modifications of homologous low density lipoproteins (LDL) make it immunogenic. In particular we have demonstrated that immunization with homologous nonenzymatically glucosylated LDL (glcLDL) results in the generation of antibodies specific to the derivatized lysine residue, and that such antibodies do not react with native LDL epitopes. In the present study we immunized rabbits with reductively glucosylated rabbit LDL and then determined the effects of the circulating antibodies on the rates of plasma clearance and on the sites of degradation of LDL in which varying degrees of glucosylation had been achieved. In normal chow-fed animals, the plasma clearance of glcLDL was retarded in proportion to the extent of lysine derivatization. In contrast, in immunized animals the clearance of glcLDL was greatly accelerated. When 10% or more of lysine residues were derivatized, clearance of glcLDL was accelerated 50- to 100-fold. Even when only 5% of lysines were derivatized, plasma clearance was accelerated 2- to 3-fold. Cholesterol feeding inhibited LDL clearance from plasma and decreased LDL uptake of LDL receptor-rich tissues. In a similar manner, glucosylation of LDL inhibited its ability to bind to the LDL receptor and redirected sites of LDL degradation away from LDL receptor-rich tissues. Thus degradation of glcLDL by liver and adrenal was markedly diminished. The presence of antibodies to glcLDL also redirected sites of degradation of the modified LDL, primarily to the reticuloendothelial cells of the liver. There was no evidence for specific targeting of glcLDL-immunoglobulin complexes to the aorta; instead they were targeted to the liver. These data suggest that the presence of humoral antibodies to modified LDL acts to rapidly remove such LDL from plasma and specifically targets such complexes to reticuloendothelial cells, primarily in the liver. In this manner such antibodies may serve a useful purpose.http://www.sciencedirect.com/science/article/pii/S0022227520386235
spellingShingle O Wiklund
J L Witztum
T E Carew
R C Pittman
R L Elam
D Steinberg
Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
Journal of Lipid Research
title Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
title_full Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
title_fullStr Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
title_full_unstemmed Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
title_short Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
title_sort turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
url http://www.sciencedirect.com/science/article/pii/S0022227520386235
work_keys_str_mv AT owiklund turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits
AT jlwitztum turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits
AT tecarew turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits
AT rcpittman turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits
AT rlelam turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits
AT dsteinberg turnoverandtissuesitesofdegradationofglucosylatedlowdensitylipoproteininnormalandimmunizedrabbits